title: Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
abstract: BACKGROUND
  Through a cross-sectional survey, we tried to assess whether practices of urologists and radiation oncologists are uniform when faced with similar clinical situations.
  
  
  METHODS
  A self-administered questionnaire was mailed to all French urologists and radiation oncologists. Respondents were asked about their practices through 11 case scenarios. The scenarios cover most of localized prostate cancer situations and were gradually organized depending on prostate cancer progression risk and the age of the patient. The eight first scenarios address the situation of treatment-naive patients, and the last cases were about the management of patients after radical prostatectomy. Physicians were asked to choose a treatment modality for each case. The responses were first stratified according to the intention to treat: either curative-intent treatment or palliative. The curative-treatment modality chosen were afterward assessed. The responses to clinical scenarios were compared between the two specialties.
  
  
  RESULTS
  Concerning the intention to treat, practice patterns were overall consistent except in one case. Indeed, a higher rate of radiation oncologists prefer curative-intent treatment for intermediate-risk prostate cancer in aged patients: 57.4 versus 14.6 % (p < 0.001). Each medical specialist prefers the treatment that he himself delivers (p < 0.005). For intermediate-risk prostate cancer in 65-year-old patient: 96.5 % of urologists chose radical prostatectomy versus 37.7 % of radiation oncologists (p < 0.001). Fewer urologists (almost 14 %) compared to radiation oncologists (47.5 %) would prescribe adjuvant treatment after radical prostatectomy for T3a R0 prostate cancer with post-operative PSA undetectable (p < 0.001).
  
  
  CONCLUSIONS
  Significant differences were found in therapeutic approach between the two main specialties that deal with localized prostate cancer.
authors.affiliation: Division of Urology, Academic Hospital Saint-Louis, University Paris VII, Paris, France. mehdi.ariane@hotmail.fr.
authors.forename: Mehdi Mokhtar
authors.initials: MM
authors.lastname: Ariane
authors.affiliation: Division of Urology, Academic Hospital Saint-Louis, University Paris VII, Paris, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Ploussard
authors.affiliation: Division of Urology, Clinic Beau Soleil, Montpellier, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Rebillard
authors.affiliation: Division of Urology, Academic Hospital Rangueil, University Toulouse III, Toulouse, France.
authors.forename: Bernard
authors.initials: B
authors.lastname: Malavaud
authors.affiliation: Division of Urology, Academic Hospital Rangueil, University Toulouse III, Toulouse, France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Rischmann
authors.affiliation: Division of Radiation Oncology, Academic Hospital Saint-Louis, University Paris VII, Paris, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Hennequin
authors.affiliation: Division of Urology, Academic Hospital Saint-Louis, University Paris VII, Paris, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Mongiat-Artus
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001291:Attitude of Health Personnel; D001918:Brachytherapy / Q000592:standards*; D003430:Cross-Sectional Studies; D019468:Disease Management; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000592:standards*; D011468:Prostatectomy / Q000592:standards*; D011471:Prostatic Neoplasms / Q000628:therapy*; D018787:Radiation Oncology; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D014572:Urology; D000078329:Workforce
keywords: Management; Prostate cancer; Radical prostatectomy; Radiotherapy
references.citation: J Clin Oncol. 2011 Jun 1;29(16):2185-90
references.pmid: 21464416
references.citation: JAMA. 2004 Jun 9;291(22):2713-9
references.pmid: 15187052
references.citation: J Clin Oncol. 2003 Dec 15;21(24):4532-9
references.pmid: 14673040
references.citation: Eur Urol. 2010 Dec;58(6):831-5
references.pmid: 20800964
references.citation: CA Cancer J Clin. 2009 Nov-Dec;59(6):379-90
references.pmid: 19841280
references.citation: Eur Urol. 2011 Jan;59(1):61-71
references.pmid: 21056534
references.citation: Prog Urol. 2007 Nov;17(6):1159-230
references.pmid: 18153992
references.citation: Med Care. 2014 Jul;52(7):579-85
references.pmid: 24926704
references.citation: N Engl J Med. 2013 Jan 31;368(5):436-45
references.pmid: 23363497
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: J Clin Oncol. 1988 Nov;6(11):1736-45
references.pmid: 3054004
references.citation: Qual Saf Health Care. 2003 Feb;12(1):18-23
references.pmid: 12571340
references.citation: Eur Urol. 2009 Jan;55(1):1-8
references.pmid: 18805628
references.citation: J Clin Oncol. 2010 Jan 1;28(1):126-31
references.pmid: 19917860
references.citation: Arch Intern Med. 2010 Mar 8;170(5):440-50
references.pmid: 20212180
references.citation: JAMA. 2000 Jun 28;283(24):3217-22
references.pmid: 10866869
references.citation: Cancer. 2008 Jun 15;112(12):2664-70
references.pmid: 18433013
references.citation: Eur Urol. 2013 Apr;63(4):597-603
references.pmid: 23159452
references.citation: J Clin Oncol. 2008 Aug 1;26(22):3735-42
references.pmid: 18669460
references.citation: Curr Oncol. 2012 Dec;19(Suppl 3):S37-44
references.pmid: 23355792
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Urol Oncol. 2009 Jan-Feb;27(1):67-71
references.pmid: 19111801
references.citation: Ann Oncol. 2010 May;21 Suppl 5:v129-33
references.pmid: 20555062
references.citation: JAMA. 1998 Sep 16;280(11):969-74
references.pmid: 9749478